Fundraising Fox
Klyne
2 employees on LinkedIn · 2 known investors
Find your way into Klyne
Sign up to see every warm intro you have to Klyne
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Klyne team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Klyne develops binding affinity models for molecular prediction and offers a low-cost virtual screening service aimed at hit discovery and hit-to-lead optimization projects in drug discovery labs. It targets companies working on early-stage pharmaceutical research with limited budgets.
Investors · 2
Fifty Yearslisted by Fifty YearsSan Francisco · $250K – $2M
How we know: Fifty Years's portfolio page · the VCSheet dataset · Not right? Tell us
Frequently asked questions
- What does Klyne do?
- Klyne develops binding affinity models for molecular prediction and offers a low-cost virtual screening service aimed at hit discovery and hit-to-lead optimization projects in drug discovery labs. It targets companies working on early-stage pharmaceutical research with limited budgets.
- Who are Klyne's investors?
- Klyne's investors include Fred Ehrsam, Fifty Years.